{"symbol":"BSX","fiscalQuarter":"Q3-2025","reportDate":"2025-10-22","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2025","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 3.95%","keyNumbers":[{"metric":"EPS","actual":"$0.75","expected":"N/A","surprise":"+5.63%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They noted ongoing investments in innovation to drive future growth."],"summary":"Overall, management expressed confidence in the company's ability to navigate market challenges. They emphasized a focus on innovation and customer needs."},"guidanceChanges":{"summary":"No forward guidance was provided during this earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock rose by nearly 4% in response, likely driven by management's optimistic outlook on product performance and innovation efforts. However, the lack of revenue data and guidance leaves some uncertainty for investors looking for future direction.","metaDescription":"Boston Scientific (BSX) Q3 2025 earnings: EPS beat by 5.63%. Stock up 3.95%. Full breakdown."}}